Table 4.
All age groups, 0–101 years | Children, 0–17 years | |||
---|---|---|---|---|
All AMPS | All non-AMPs | All AMPS | All non-AMPs | |
Patients of prescriber physicians | ||||
ADRs, Grades I–IV | 67 | 612 | 37 | 574 |
Prescriptions | 94,734 | 148,413 | 59,265 | 120,638 |
ADRs/prescriptions (%) | 0.071 | 0.412 | 0.062 | 0.453 |
Patients with ADR | 65 | 569 | 36 | 532 |
Patients with prescriptions | 12,956 | 11,652 | 9,162 | 8,550 |
Patients with ADR/with prescriptions (%) | 0.502 | 4.88 | 0.393 | 6.22 |
Patients of all physicians | ||||
ADRs, Grades III–IV only | 7 | 82 | 2 | 59 |
Prescriptions | 311,731 | 405,814 | 193,851 | 243,560 |
ADRs/prescriptions (%) | 0.002 | 0.020 | 0.001 | 0.024 |
Patients with ADR | 7 | 82 | 2 | 59 |
Patients with prescriptions | 44,662 | 39,473 | 28,355 | 25,587 |
Patients with ADR/with prescriptions (%) | 0.016 | 0.208 | 0.007 | 0.231 |
ADRs adverse drug reactions, AMPs anthroposophic medicinal products, non-AMPs all medicinal products except AMPs